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Abstract 
Introduction:  Pregnancy after organ transplantation is becoming increasingly common. However, reports of the 
anesthesia for such patients are rare. Heart transplant recipients are always accompanied with pathophysiological 
changes and present anesthesiologists with challenge.
Case description: We reported a case of anesthesia management of gravida undergoing cesarean section 10 years 
after cardiac transplantation. We used two points spinal and epidural anesthesia, combined with phenylephrine 
throughout the surgery. The course was absolutely successful and both mother and baby got good results.
Discussion and evaluation: Physiology of heart transplant recipients and key points of anesthesia management 
were discussed.
Conclusions: Spinal anesthesia can be performed in heart transplant recipients, however, we have to think twice 
before anesthesia for this kind of patients.
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Introduction
For severe end-stage heart disease, cardiac transplanta-
tion is a life-saving procedure for those are refractory 
to medical therapies. Nowadays, the overall survival of 
recipients has increased to about 90 % at 1 year and more 
than 75  % at 7  years post transplantation (Taylor et  al. 
2007). In these heart transplanted recipients, women 
constitute one-third and about 20 % of them are in repro-
ductive age (Alston et al. 2001).
Cardiac-transplanted patients present anesthesiolo-
gists with challenging problems related to the function of 
the denervated heart and their complex drug therapies. 
If combined with pregnancy, changes accompanied with 
pregnancy should be taken into account, and the condi-
tion will be more complicated.
We reported the successful outcome of anesthesia for 
a pregnancy undergoing cesarean section  10  years after 
cardiac transplantation for a dilated cardiomyopathy. We 
used intrathecal anesthesia, combined with vasoconstric-
tor throughout the surgery. The course was uneventful 
and hemodynamic stable.
Case description
A 33-year-old pregnant woman was admitted to hospi-
tal on 19th, March, 2015 with gestation of 34 weeks and 
3 days. She underwent orthotopic cardiac transplantation 
in September 2005 for a dilated cardiomyopathy. Dur-
ing remaining 10  years she was treated with immuno-
suppressor tacrolimus and mycophenolate on schedule 
and no rejection episode was noted. Seven months ago 
she found she was pregnant and stopped mycopheno-
late according to the doctor’s advice. During pregnancy, 
antenatal cares were performed timely and no obstetrical 
complications were found. After discussion of obstetri-
cians, cardiologists, neonatologists and anesthesiologists, 
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cesarean section was decided to perform on gestation of 
35 weeks for her history of heart transplantation.
Preoperative evaluation
The parturient was 35 weeks gestation and 56 kg on the 
day of surgery (24th, March, 2015). The patient’s general 
condition was good and cardiac function classification 
was stage one. ECG showed sinus tachycardia: 110 beats 
per minute. Cardiac ultrasound showed left ventricular 
wall thickening and ascending aortic dilatation. Labo-
ratory tests: Hb 95  g/l. WBC 13.2 ×  109/l. Coagulation 
function, liver and kidney function were normal.
Anesthesia procedure
The patient fasted overnight and no preoperative medi-
cation was administered. Tacrolimus was treated orally 
1.5 mg/12 h until morning of surgery. On arrival in the 
operating room, pulse oxygen saturation, electrocardio-
gram, and non-invasive blood pressure were monitored, 
and the baseline values were recorded. Oxygen (5 l/min) 
by facemask was given until delivery. An intravenous 
catheter was placed and the patient was preloaded with 
Lactated Ringer’s Solution (12–15  ml/kg) before induc-
tion of spinal anesthesia. Left radial artery was punctured 
and catheter was inserted to measure direct blood pres-
sure. Deep venous puncture was not performed.
Two points of combined spinal and epidural anesthe-
sia (CSEA) was performed with the patient in the lateral 
decubitus position. Firstly at L2-3 intervertebral space 
epidural catheter was placed 3 cm cephalic through epi-
dural needle. Then at L3-4 intervertebral space a 25G 
spinal Quincke needle was introduced to subarachnoid 
space, after free flow of cerebral spinal fluid (CSF), 0.5 % 
ropivacaine 10 mg was injected at a rate of 0.1 ml/s. The 
patient was immediately placed in the supine position 
with uterus leftward.
At the same time when anesthesia performed, intrave-
nous phenylephrine was pumping continuously at rate 
of 0.1 µg/kg.min to prevent hypotension. After injection 
of intrathecal medication, the rate of phenylephrine was 
adjusted between 0.1 and 0.3  µg/kg min according to 
patient’s hemodynamic condition.
When satisfactory anesthesia level (T6) was achieved, 
surgery began. Five minutes later, a male infant was deliv-
ered, weighing 2150  g with Apgar score of 10 at 1 and 
5  min after delivery. Immediately after baby was born, 
oxytocin 10 units was given intramuscular in the uterus 
and 10 units intravenous dripping with added to 500 ml 
Lactated Ringer’s Solution. The surgery lasted for 35 min 
and the course was uneventful, the parturient com-
plained no discomfort. During the surgery, blood pres-
sure maintained at 108–122/65–82mmHg, and heart rate 
at 80–108 beats/min. The total volume of infusion fluid 
was 1500  ml, blood loss was 200  ml, urine was 100  ml. 
When the operation was over, epidural morphine 2  mg 
was given via epidural catheter and patient controlled 
intravenous analgesia (PCIA) pump was treated. The 
pump was total 100 ml contained 1 µg/ml sufentanil with 
background flow 2 ml/h, bolus 4 ml, locked time 30 min.
She was taken care in intensive care unit postoperaton. 
3.5 h later, anesthesia was completely subsided. Tacroli-
mus was treated orally 1.5  mg/12  h continually. Breast 
feeding was not allowed for the risk of immunosuppres-
sant to baby. Six days after delivery she got good recovery 
with no complications and was discharged from hospi-
tal together with her infant. Follow up was carried out 
5 months and no episode was found.
Discussion and evaluation
For heart transplanted recipients undergoing non-car-
diac surgeries, we should recognize the physiology of the 
transplanted heart, pharmacologic effects of immuno-
suppressive medications and complications accompanied 
by heart transplantation. For pregnant women, obstetri-
cal conditions also should be considered. We should take 
care of the patients from preoperative period, intraopera-
tive period, and postoperative period.
Physiology of transplanted heart and preoperative 
evaluation and preparation
The transplanted heart is denervated. The remaining 
atrial cuff of recipient is innervated but hemodynamic 
unimportant. The donor atrium is denervated but is 
responsible for the electrophysiological responses of the 
transplanted heart. It retains its intrinsic control mech-
anisms which include: a normal Frank-Starling effect, 
normal impulse formation and conductivity, intact ɑ and 
β receptors responding to circulating catecholamines 
(Blasco et al. 2009). At rest, the heart rate is faster than 
normal at about 90–100 beats per minute because lack of 
vagal tone (Ramakrishna et al. 2009).
Including the function of transplanted heart, we also 
have to notice the complications following heart trans-
plantation and the influence of anti-rejection drugs in the 
heart transplanted recipients. Nearly 75 % of post-trans-
plant recipients develop mild to moderate hypertension 
as a result of immunosuppressor therapy (O’Boyle et al. 
2010). Because cardiac responsiveness during exercise 
is dependent on circulating catecholamines, beta block-
ers are best avoided after heart transplantation (Blasco 
et  al. 2009). The denervated heart is vulnerable to an 
accelerated process of coronary atherosclerosis. Allograft 
coronary atherosclerotic disease is present in 10–20 % of 
patients 1 year after transplantation and in near 50 % by 
5 years (Ng and Cassorla 2007). Even in angiographically 
normal coronary arteries, coronary luminal narrowing 
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may develop insidiously. The lack of afferent innerva-
tion renders episodes of myocardial ischaemia silent in 
these patients. Therefore, diagnostic ECG is essential 
in the perioperative period. If coagulation function is 
abnormal, intravertebral anesthesia should be avoided. 
Many immune inhibitors, nonstemidial anti-inflamma-
tory drugs are nephrotoxic drugs, so anesthetics that are 
excreted mainly by renal clearance should be avoided. 
Immunosuppressant caused infection remains a major 
cause of death (Aguero et  al. 2008; Van de Beek et  al. 
2008), thus aseptic technique should be paramount. Inva-
sive monitoring techniques and all forms of instrumenta-
tion should be handled with sterile manipulation.
Pregnancy is associated with significant hemodynamic 
demands. Blood volume increases by 40  % and cardiac 
output by 30  %. The transplanted heart is denervated 
and so responds to these demands with adaptive mecha-
nisms: an increase in central venous pressure and preload 
leads to an increase in stroke volume. Circulating cat-
echolamines allow further increases in cardiac output by 
increasing heart rate and contractility. If pre-pregnancy 
cardiac function is normal, the transplanted heart is gen-
erally able to adjust to these demands (Wu et  al. 2007). 
In reported cases of pregnancies following heart trans-
plantation, outcomes of pregnancy have been good with 
no recurrence of cardiac dysfunction in the transplanted 
heart (Armenti et  al. 2008; Humphreys et  al. 2012; 
Kalinka et al. 2014). However, the incidence of maternal 
complications is increased in heart transplant recipients 
(Miniero et al. 2004; Sibanda et al. 2007). Hypertension is 
a significant problem both prior to and during pregnancy 
(Zurbano et  al. 2012; Armenti et  al. 2004; Coscia et  al. 
2010) and it requires meticulous control. The incidence 
of preeclampsia is approximately 20  % (Zurbano et  al. 
2012; Armenti et al. 2004; Coscia et al. 2010).
Anesthesia management
Cesarean section is performed in about 30  % of heart 
transplanted recipients (Cowan et  al. 2012; Wielgos 
et  al. 2009). No matter what anesthesia method to per-
form, we should maintain hemodynamic stable and pro-
tect cardiac function, and keep mother and baby safe. 
Both general and intravertebral anesthesia were success-
fully performed in heart transplanted patients (Valerio 
et al. 2014; Allard et al. 2004). But for pregnant women, 
the better anesthesia choice is intravertebral anesthesia 
which produces less impact on baby compared with gen-
eral anesthesia. This patient is with good cardiac func-
tion, normal coagulation function and no other serious 
complications, so spinal anesthesia was performed to 
prevent impact of general anesthetics to baby. For the 
post heart transplanted patients, several points we should 
notice:
Firstly, appropriate anesthesia level must be controlled. 
For too high anesthesia level will inhibit sympathetic 
nerve, dilate vessel which is unfavorable for transplanted 
heart. The same, too low anesthesia level is not enough 
for the surgery, and pain will increase oxygen consump-
tion of myocardium. We controlled anesthesia level at 
T6, and got satisfactory effect and hemodynamic stable.
Secondly, appropriate fluid infusion. The normal heart 
increases its cardiac output via neural stimuli leading to 
increases in heart rate and contractility (Schwaiblmair 
et  al. 1999), while the denervated heart lacks the ability 
to respond acutely to hypovolaemia or hypotension with 
reflex tachycardia, and dependent upon venous return 
with an initial increase in left ventricular end-diastolic 
volume (Blasco et  al. 2009; Swami et  al. 2011), which 
mediates an increase in stroke volume and ejection frac-
tion by means of the Frank-Starling mechanism. Ade-
quate preload must be ascertained preoperatively and 
intravascular volume status maintained intraoperatively. 
However, too much fluid is also not beneficial for dener-
vated heart, for risks to increase heart load and lead to 
heart failure. We preloaded 12–15 ml/kg Ringer lactate 
solution before anesthesia to resist vasodilation caused 
by anesthesia.
Thirdly, vasoconstrictor phenylephrine was treated 
intravenously to maintain intravascular volume and keep 
hemodynamic stable. Phenylephrine is α receptor ago-
nist. As intraspinal anesthesia dilates vessel and relatively 
decrease blood volume, so phenylephrine is helpful to 
maintain intravascular volume and keep hemodynamic 
stable, and doesn’t affect myocardial contractivity. The 
transplanted heart is more sensitive to drugs directly acts 
on heart such as adrenaline, norepinephrine, isoprensline 
than those indirectly drugs as ephedrine, metaradrine. 
The heart rate shows no response to drugs like atropine, 
neostigmine, phenylephrine, but will respond to isopro-
terenol, ephedrine, dopamine.
Fourth, antiseptic measures. Maternal infection is of 
significant concern, although it is relatively rare in prac-
tice. It is recommended that all procedures are performed 
with strict asepsis and antibiotic prophylaxis be used for 
all operative and instrumental deliveries. We sterilized 
carefully before spinal anesthesia procedures, and antibi-
otics were used throughout the surgery. Invasive central 
venous pressure (CVP) was not used in this case because 
of the patient’s preoperative stability, minimal surgical 
risk, and the low possibility of massive fluid infusion.
Postoperative care
The parturient was taken good care in ICU. Immunosup-
pressant drugs tacrolimus was continued to use postop-
eratively as Knight and Morris suggested (Knight and 
Morris 2007). Analgesia must be good enough to avoid 
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increasing oxygen consumption of myocardium. In addi-
tion, intravenous fluids must be well maintained, and 
urine output monitored.
Conclusions
For anesthesia in gravidas following heart transplan-
tation, we should recognize the physiology of the 
transplanted heart, pharmacologic effects of immu-
nosuppressive medications, obstetrical condition of 
patients. In addition, understand the importance of 
preload dependence, proper administration of direct vas-
oactive drugs if needed, and aware infectious risk. Take 
care of the patient from preoperative period, intraopera-
tive period, and postoperative period. The most impor-
tant is to make cardiac function normal, hemodynamic 
stable, enable mother and baby safe.
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